
Applied DNA Achieves Program Milestone in Development of Linear DNA Veterinary COVID-19 Vaccine
February 2nd, 2021
Applied DNA Achieves Program Milestone in Development of Linear DNA Veterinary COVID-19 Vaccine
February 2nd, 2021
Linea™ COVID-19 Assay Kit: Detection of Multiple SARS-CoV-2 Variants
January 19th, 2021
Assay Kit Can Detect Gene Mutation Found in SARS-CoV-2 U.K. Variant B.1.1.7
January 8th, 2021
APDN, CLEARED4 Partner on COVID-19 Testing Program
December 29th, 2020
APDN Awarded Pooled Surveillance Testing Contract Valued at Up to $2M
December 17th, 2020
NY Winter COVID-19 Plan Drives Demand for Applied DNA’s Pooled Surveillance Testing Program
December 11th, 2020
Applied DNA to Provide COVID-19 Surveillance Testing to Stony Brook Basketball
December 1st, 2020
APDN, Evvivax and GVS Receive Approval for Veterinary COVID-19 Clinical Trial
November 30th, 2020
Applied DNA Significantly Expands Addressable Market for Linea™ COVID-19 Assay Kit via Successful Amendment to FDA EUA
November 25th, 2020